Pharmacokinetic and Safety Study of Oral Lofexidine in Neonates Experiencing Opioid Withdrawal Due to Intrauterine Exposure to Opioids
Clinical trial NCT06047834 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06047834
- Sponsor
- BioCorRx Pharmaceuticals Inc
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-02
- Primary completion
- 2025-05-11
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.